ArticleJournal of neurosurgery. Case lessons2025
Candida glabrata vertebral osteomyelitis following L3-4 transforaminal lumbar fusion: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCandida vertebral osteomyelitis is rare, particularly following instrumented spine surgery. Candida glabrata presents additional management challenges due to its frequent resistance to azole antifungal treatment and its association with immunocompromised hosts. OBSERVATIONS: A 74-year-old immunosuppressed man underwent L3-4 transforaminal lumbar interbody fusion with cyst excision. Seven weeks postoperatively, he presented with constitutional symptoms and elevated inflammatory markers but was discharged with presumed viral illness. Nine months after surgery, imaging revealed cage displacement. Intraoperative cultures during hardware removal identified C. glabrata. The patient underwent repeat irrigation and debridement with hardware exchange and was treated with intravenous micafungin and oral fluconazole and later transitioned to posaconazole. Despite ongoing antifungal therapy, inflammatory markers remained elevated, and follow-up imaging showed progressive vertebral destruction without hardware failure. The patient continues on chronic antifungal suppression with multidisciplinary monitoring. LESSONS: This case highlights the diagnostic and therapeutic challenges of postoperative C. glabrata vertebral osteomyelitis. Early suspicion, culture confirmation, and organism-specific antifungal therapy, alongside timely surgical management, are critical to achieving infection control and preserving spinal stability in immunosuppressed patients. https://thejns.org/doi/10.3171/CASE25555.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.